MDGL logo

Madrigal Pharmaceuticals (MDGL) Operating profit

annual operating profit:

-$497.88M-$117.38M(-30.85%)
December 31, 2024

Summary

  • As of today (June 2, 2025), MDGL annual operating income is -$497.88 million, with the most recent change of -$117.38 million (-30.85%) on December 31, 2024.
  • During the last 3 years, MDGL annual operating profit has fallen by -$255.39 million (-105.32%).
  • MDGL annual operating profit is now -718.17% below its all-time high of $80.54 million, reached on December 31, 2009.

Performance

MDGL Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDGLincome statement metrics

quarterly operating profit:

-$79.31M-$12.31M(-18.38%)
March 31, 2025

Summary

  • As of today (June 2, 2025), MDGL quarterly operating income is -$79.31 million, with the most recent change of -$12.31 million (-18.38%) on March 31, 2025.
  • Over the past year, MDGL quarterly operating profit has increased by +$72.73 million (+47.83%).
  • MDGL quarterly operating profit is now -167.11% below its all-time high of $118.17 million, reached on September 30, 2009.

Performance

MDGL quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDGLincome statement metrics

TTM operating profit:

-$425.15M+$72.73M(+14.61%)
March 31, 2025

Summary

  • As of today (June 2, 2025), MDGL TTM operating income is -$425.15 million, with the most recent change of +$72.73 million (+14.61%) on March 31, 2025.
  • Over the past year, MDGL TTM operating profit has increased by +$29.05 million (+6.40%).
  • MDGL TTM operating profit is now -554.80% below its all-time high of $93.48 million, reached on March 31, 2010.

Performance

MDGL TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDGLincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

MDGL Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-30.9%+47.8%+6.4%
3 y3 years-105.3%-37.7%-72.1%
5 y5 years-424.2%-108.7%-270.1%

MDGL Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-105.3%at low-37.7%+51.2%-72.1%+22.4%
5 y5-year-424.2%at low-108.7%+51.2%-270.1%+22.4%
alltimeall time-718.2%at low-167.1%+51.2%-554.8%+22.4%

MDGL Operating profit History

DateAnnualQuarterlyTTM
Mar 2025
-
-$79.31M(+18.4%)
-$425.15M(-14.6%)
Dec 2024
-$497.88M(+30.8%)
-$67.00M(-42.4%)
-$497.87M(-9.2%)
Sep 2024
-
-$116.30M(-28.4%)
-$548.05M(+3.4%)
Jun 2024
-
-$162.54M(+6.9%)
-$530.28M(+16.8%)
Mar 2024
-
-$152.04M(+29.8%)
-$454.20M(+19.4%)
Dec 2023
-$380.50M(+29.6%)
-$117.18M(+18.9%)
-$380.50M(+9.1%)
Sep 2023
-
-$98.53M(+14.0%)
-$348.62M(+5.5%)
Jun 2023
-
-$86.45M(+10.4%)
-$330.50M(+5.1%)
Mar 2023
-
-$78.34M(-8.2%)
-$314.32M(+7.1%)
Dec 2022
-$293.57M(+21.1%)
-$85.30M(+6.1%)
-$293.57M(+7.6%)
Sep 2022
-
-$80.41M(+14.4%)
-$272.87M(+6.7%)
Jun 2022
-
-$70.27M(+22.0%)
-$255.62M(+3.5%)
Mar 2022
-
-$57.59M(-10.9%)
-$247.09M(+1.9%)
Dec 2021
-$242.48M(+17.3%)
-$64.60M(+2.3%)
-$242.48M(+2.1%)
Sep 2021
-
-$63.16M(+2.3%)
-$237.44M(+1.9%)
Jun 2021
-
-$61.74M(+16.5%)
-$233.06M(+5.2%)
Mar 2021
-
-$52.98M(-11.0%)
-$221.65M(+7.2%)
Dec 2020
-$206.67M(+117.6%)
-$59.55M(+1.3%)
-$206.67M(+16.7%)
Sep 2020
-
-$58.79M(+16.8%)
-$177.07M(+24.3%)
Jun 2020
-
-$50.33M(+32.4%)
-$142.48M(+24.0%)
Mar 2020
-
-$38.01M(+26.9%)
-$114.86M(+20.9%)
Dec 2019
-$94.97M(+133.4%)
-$29.95M(+23.8%)
-$94.97M(+19.5%)
Sep 2019
-
-$24.20M(+6.6%)
-$79.47M(+19.3%)
Jun 2019
-
-$22.70M(+25.3%)
-$66.61M(+28.8%)
Mar 2019
-
-$18.12M(+25.4%)
-$51.73M(+27.2%)
Dec 2018
-$40.68M(+26.9%)
-$14.45M(+27.5%)
-$40.68M(+15.8%)
Sep 2018
-
-$11.33M(+44.8%)
-$35.14M(+8.3%)
Jun 2018
-
-$7.83M(+10.7%)
-$32.44M(-1.9%)
Mar 2018
-
-$7.07M(-20.7%)
-$33.06M(+3.1%)
Dec 2017
-$32.06M(+27.1%)
-$8.91M(+3.2%)
-$32.06M(+3.7%)
Sep 2017
-
-$8.64M(+2.3%)
-$30.91M(-15.0%)
Jun 2017
-
-$8.44M(+38.9%)
-$36.36M(+19.0%)
Mar 2017
-
-$6.08M(-21.7%)
-$30.56M(+21.2%)
Dec 2016
-$25.22M(+680.2%)
-$7.75M(-45.0%)
-$25.22M(+37.2%)
Sep 2016
-
-$14.09M(+434.0%)
-$18.39M(+255.3%)
Jun 2016
-
-$2.64M(+257.6%)
-$5.18M(-76.5%)
Mar 2016
-
-$738.00K(-19.6%)
-$22.04M(-47.1%)
Dec 2015
-$3.23M(-96.1%)
-$918.40K(+4.4%)
-$41.63M(-31.3%)
Sep 2015
-
-$880.00K(-95.5%)
-$60.61M(-23.5%)
Jun 2015
-
-$19.50M(-4.1%)
-$79.18M(-2.7%)
Mar 2015
-
-$20.33M(+2.2%)
-$81.38M(-3.1%)
DateAnnualQuarterlyTTM
Dec 2014
-$83.95M(-4.1%)
-$19.89M(+2.3%)
-$83.95M(-4.1%)
Sep 2014
-
-$19.45M(-10.4%)
-$87.50M(-2.6%)
Jun 2014
-
-$21.70M(-5.3%)
-$89.85M(-0.4%)
Mar 2014
-
-$22.91M(-2.3%)
-$90.21M(+3.0%)
Dec 2013
-$87.56M(+43.7%)
-$23.44M(+7.6%)
-$87.56M(+7.0%)
Sep 2013
-
-$21.79M(-1.2%)
-$81.82M(+9.7%)
Jun 2013
-
-$22.06M(+8.9%)
-$74.56M(+11.9%)
Mar 2013
-
-$20.26M(+14.4%)
-$66.63M(+9.3%)
Dec 2012
-$60.94M(+34.1%)
-$17.70M(+21.8%)
-$60.94M(+14.0%)
Sep 2012
-
-$14.54M(+2.9%)
-$53.48M(+4.5%)
Jun 2012
-
-$14.13M(-3.0%)
-$51.16M(+4.3%)
Mar 2012
-
-$14.56M(+42.3%)
-$49.03M(+7.9%)
Dec 2011
-$45.43M(+23.1%)
-$10.24M(-16.2%)
-$45.43M(+4.3%)
Sep 2011
-
-$12.22M(+1.7%)
-$43.56M(+4.8%)
Jun 2011
-
-$12.01M(+9.5%)
-$41.57M(+7.7%)
Mar 2011
-
-$10.97M(+31.1%)
-$38.61M(+4.6%)
Dec 2010
-$36.90M(-145.8%)
-$8.37M(-18.2%)
-$36.90M(+3.9%)
Sep 2010
-
-$10.23M(+13.1%)
-$35.51M(-138.2%)
Jun 2010
-
-$9.04M(-2.3%)
$92.89M(-0.6%)
Mar 2010
-
-$9.26M(+32.6%)
$93.48M(+16.1%)
Dec 2009
$80.54M(-185.9%)
-$6.98M(-105.9%)
$80.54M(+30.6%)
Sep 2009
-
$118.17M(-1498.0%)
$61.66M(-174.3%)
Jun 2009
-
-$8.45M(-61.9%)
-$82.97M(-14.9%)
Mar 2009
-
-$22.20M(-14.2%)
-$97.46M(+4.0%)
Dec 2008
-$93.71M(+41.5%)
-$25.86M(-2.2%)
-$93.71M(+11.3%)
Sep 2008
-
-$26.45M(+15.3%)
-$84.19M(+15.1%)
Jun 2008
-
-$22.95M(+24.4%)
-$73.13M(+8.1%)
Mar 2008
-
-$18.45M(+12.9%)
-$67.65M(+2.2%)
Dec 2007
-$66.22M(+11.9%)
-$16.34M(+6.2%)
-$66.22M(+5.3%)
Sep 2007
-
-$15.39M(-11.9%)
-$62.88M(+1.3%)
Jun 2007
-
-$17.47M(+2.7%)
-$62.06M(+39.2%)
Mar 2007
-
-$17.01M(+30.8%)
-$44.59M(+61.7%)
Dec 2006
-$59.15M(-16.9%)
-$13.01M(-10.8%)
-$27.58M(+89.2%)
Sep 2006
-
-$14.58M(-21.2%)
-$14.58M(-21.2%)
Dec 2005
-$71.18M(+57.0%)
-
-
Mar 2005
-
-$18.50M(+239.3%)
-$18.50M(+239.3%)
Dec 2004
-$45.35M(+60.3%)
-
-
Mar 2004
-
-$5.45M
-$5.45M
Dec 2003
-$28.29M(+288.0%)
-
-
Dec 2002
-$7.29M(+1718.5%)
-
-
Dec 2001
-$401.00K
-
-

FAQ

  • What is Madrigal Pharmaceuticals annual operating income?
  • What is the all time high annual operating profit for Madrigal Pharmaceuticals?
  • What is Madrigal Pharmaceuticals annual operating profit year-on-year change?
  • What is Madrigal Pharmaceuticals quarterly operating income?
  • What is the all time high quarterly operating profit for Madrigal Pharmaceuticals?
  • What is Madrigal Pharmaceuticals quarterly operating profit year-on-year change?
  • What is Madrigal Pharmaceuticals TTM operating income?
  • What is the all time high TTM operating profit for Madrigal Pharmaceuticals?
  • What is Madrigal Pharmaceuticals TTM operating profit year-on-year change?

What is Madrigal Pharmaceuticals annual operating income?

The current annual operating profit of MDGL is -$497.88M

What is the all time high annual operating profit for Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals all-time high annual operating income is $80.54M

What is Madrigal Pharmaceuticals annual operating profit year-on-year change?

Over the past year, MDGL annual operating income has changed by -$117.38M (-30.85%)

What is Madrigal Pharmaceuticals quarterly operating income?

The current quarterly operating profit of MDGL is -$79.31M

What is the all time high quarterly operating profit for Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals all-time high quarterly operating income is $118.17M

What is Madrigal Pharmaceuticals quarterly operating profit year-on-year change?

Over the past year, MDGL quarterly operating income has changed by +$72.73M (+47.83%)

What is Madrigal Pharmaceuticals TTM operating income?

The current TTM operating profit of MDGL is -$425.15M

What is the all time high TTM operating profit for Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals all-time high TTM operating income is $93.48M

What is Madrigal Pharmaceuticals TTM operating profit year-on-year change?

Over the past year, MDGL TTM operating income has changed by +$29.05M (+6.40%)
On this page